Publicaciones en las que colabora con Carmen Conde Muro (22)

2023

  1. Assessment of anti-malondialdehyde-acetaldehyde antibody frequencies in rheumatoid arthritis with new data from two independent cohorts, meta-analysis, and meta-regression

    Arthritis Research and Therapy, Vol. 25, Núm. 1

  2. HOXA5 is a key regulator of class 3 semaphorins expression in the synovium of rheumatoid arthritis patients

    Rheumatology (United Kingdom), Vol. 62, Núm. 7, pp. 2621-2630

2022

  1. Central Role of Semaphorin 3B in a Serum-Induced Arthritis Model and Reduced Levels in Patients With Rheumatoid Arthritis

    Arthritis and Rheumatology, Vol. 74, Núm. 6, pp. 972-983

  2. ROCK inhibition with Y-27632 reduces joint inflammation and damage in serum-induced arthritis model and decreases in vitro osteoclastogenesis in patients with early arthritis

    Frontiers in Immunology, Vol. 13

2020

  1. A predominant involvement of the triple seropositive patients and others with rheumatoid factor in the association of smoking with rheumatoid arthritis

    Scientific Reports, Vol. 10, Núm. 1

  2. All-trans retinoic acid inhibits migration and invasiveness of rheumatoid fibroblast-like synoviocytes

    Journal of Pharmacology and Experimental Therapeutics, Vol. 372, Núm. 2, pp. 185-192

  3. Non-Canonical WNT5A Signaling Through RYK Contributes to Aggressive Phenotype of the Rheumatoid Fibroblast-Like Synoviocytes

    Frontiers in Immunology, Vol. 11

  4. Publisher Correction: A predominant involvement of the triple seropositive patients and others with rheumatoid factor in the association of smoking with rheumatoid arthritis (Scientific Reports, (2020), 10, 1, (3355), 10.1038/s41598-020-60305-x)

    Scientific Reports

2018

  1. Evaluation of a clinical pharmacogenetics model to predict methotrexate response in patients with rheumatoid arthritis

    Pharmacogenomics Journal, Vol. 18, Núm. 4, pp. 539-545

  2. Replication study of polymorphisms associated with response to methotrexate in patients with rheumatoid arthritis

    Scientific Reports, Vol. 8, Núm. 1

  3. Uncovering Cellular retinoic acid-binding protein 2 as a potential target for rheumatoid arthritis synovial hyperplasia

    Scientific Reports, Vol. 8, Núm. 1

2015

  1. Effect of lysophosphatidic acid receptor inhibition on bone changes in ovariectomized mice

    Journal of Bone and Mineral Metabolism, Vol. 33, Núm. 4, pp. 383-391

2014

  1. Lysophosphatidic acid receptor inhibition as a new multipronged treatment for rheumatoid arthritis

    Annals of the Rheumatic Diseases, Vol. 73, Núm. 1, pp. 298-305

2012

  1. Lysophosphatidic acid receptor 1 suppression sensitizes rheumatoid fibroblast-like synoviocytes to tumor necrosis factor-induced apoptosis

    Arthritis and Rheumatism, Vol. 64, Núm. 8, pp. 2460-2470

2010

  1. Akt activity protects rheumatoid synovial fibroblasts from Fas-induced apoptosis by inhibition of Bid cleavage

    Arthritis Research and Therapy, Vol. 12, Núm. 1

  2. Matrix metalloproteinase-8 deficiency increases joint inflammation and bone erosion in the K/BxN serum-transfer arthritis model

    Arthritis Research and Therapy, Vol. 12, Núm. 6

2009

  1. Poly(ADP-ribose) polymerase suppression protects rheumatoid synovial fibroblasts from Fas-induced apoptosis

    Rheumatology, Vol. 48, Núm. 5, pp. 483-489

2008

  1. Poly(ADP-ribose) polymerase inhibition reduces tumor necrosis factor-induced inflammatory response in rheumatoid synovial fibroblasts

    Annals of the Rheumatic Diseases, Vol. 67, Núm. 5, pp. 631-637

2007

  1. Study of DNASE I gene polymorphisms in systemic lupus erythematosus susceptibility [3]

    Annals of the Rheumatic Diseases

2006

  1. Association of a non-synonymous single-nucleotide polymorphism of DNASEI with SLE susceptibility

    Rheumatology, Vol. 45, Núm. 7, pp. 819-823